News
Sunrun (RUN) Just Flashed Golden Cross Signal: Do You Buy?
After reaching an important support level, Sunrun (RUN) could be a good stock pick from a technical perspective. RUN surpassed resistance at the 20-day moving average, suggesting a short-term
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
Nuvation Bio Inc. (NUVB) has been beaten down lately with too much selling pressure. While the stock has lost 24.1% over the past four weeks, there is light at the end of the tunnel as it is now in
JPM's Q4 Earnings Beat Estimates on Solid Trading & NII, Weak IB Hurts
Impressive trading performance and higher net interest income (NII) drove JPMorgan’s JPM adjusted fourth-quarter 2025 earnings of $5.23 per share. The bottom line handily surpassed the Zacks
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Nice (NICE) Is Considered a Good Investment by Brokers: Is That True?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is SharkNinja, Inc. (SN) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Bulls Look Optimistic About Gold.com (GOLD): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is Modine (MOD) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Brokers Suggest Investing in Chewy (CHWY): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Here's What Key Metrics Tell Us About Delta (DAL) Q4 Earnings
For the quarter ended December 2025, Delta Air Lines (DAL) reported revenue of $16 billion, up 2.9% over the same period last year. EPS came in at $1.55, compared to $1.85 in the year-ago quarter.
Is Visa (V) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Here's What Key Metrics Tell Us About JPMorgan Chase & Co. (JPM) Q4 Earnings
JPMorgan Chase & Co. (JPM) reported $45.8 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.1%. EPS of $5.23 for the same period compares to $4.81 a
Brokers Suggest Investing in CrowdStrike (CRWD): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
The Bank of New York Mellon (BK) Reports Q4 Earnings: What Key Metrics Have to Say
The Bank of New York Mellon Corporation (BK) reported $5.18 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6.9%. EPS of $2.08 for the same period
Wall Street Analysts Think Roku (ROKU) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Sunrun (RUN) Recently Broke Out Above the 50-Day Moving Average
From a technical perspective, Sunrun (RUN) is looking like an interesting pick, as it just reached a key level of support. RUN recently overtook the 50-day moving average, and this suggests a
United Airlines to Report Q4 Earnings: What's in the Offing?
United Airlines UAL is scheduled to report fourth-quarter 2025 results on Jan. 20, after market close.
The Zacks Consensus Estimate for fourth-quarter 2025 earnings has declined 7.6% over the past
EMCOR's Record Backlog: A Growth Catalyst or Execution Challenge?
EMCOR Group, Inc. EME continues to deliver standout operating performance, and its record remaining performance obligations (RPOs) underscore the visibility supporting future growth. As of Sept. 30
5 AI Stocks Positioned to Win, No Matter What
AI is a fast-growing market whose outlook has yet to be fully reflected in its stock prices. While it's hard to say for certain which AI infrastructure, model builder, or application will stand
Company News for Jan 13, 2026
- Shares of Exxon Mobil Corporation (XOM) declined 0.5% after President Donald Trump threatened to ban the company from Venezuela’s oil market, saying that he wasn’t happy with the company’s
Are Options Traders Betting on a Big Move in WAT Stock?
Investors in Waters Corporation WAT need to pay close attention to the stock based on moves in the options market lately. That is because the Feb. 20, 2026 $195 Put had some of the highest implied
Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes
Sanofi SNY announced that the European Commission has approved Teizeild (teplizumab) to delay the onset of stage 3 type 1 diabetes (T1D) in patients aged eight years and older with stage 2 disease


